Primary Site >> Liver Cancer
Gene >> FNDC5
| 1. | |||||||||||
| Journal: | Free Radic Biol Med. 2014 Oct;75 Suppl 1:S16. | ||||||||||
| Title: | The effect of Irisin on antioxidant system in liver. | ||||||||||
| Author: | Batirel, Saime|Bozaykut, Perinur|Mutlu Altundag, Ergul|Kartal Ozer, Nesrin|Mantzoros, Christos S | ||||||||||
| PMID: | 26461295 | ||||||||||
| 2. | |||||||||||
| Journal: | Clin Sci (Lond). 2015 Nov;129(10):839-50. | ||||||||||
| Title: | Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. | ||||||||||
| Author: | Liu, Tong-Yan|Shi, Chang-Xiang|Gao, Run|Sun, Hai-Jian|Xiong, Xiao-Qing|Ding, Lei|Chen, Qi|Li, Yue-Hua|Wang, Jue-Jin|Kang, Yu-Ming|Zhu, Guo-Qing | ||||||||||
| PMID: | 26201094 | ||||||||||
| 3. | |||||||||||
| Journal: | Biotech Histochem. 2016;91(4):242-50. | ||||||||||
| Title: | Irisin immunohistochemistry in gastrointestinal system cancers. | ||||||||||
| Author: | Aydin, S|Kuloglu, T|Ozercan, M R|Albayrak, S|Aydin, S|Bakal, U|Yilmaz, M|Kalayci, M|Yardim, M|Sarac, M|Kazez, A|Kocdor, H|Kanat, B|Ozercan, I H|Gonen, M|Bilgen, M|Balgetir, F | ||||||||||
| PMID: | 26963139 | ||||||||||
| 4. | |||||||||||
| Journal: | Peptides. 2017 Feb;88:62-66. | ||||||||||
| Title: | Increased FNDC5/Irisin expression in human hepatocellular carcinoma. | ||||||||||
| Author: | Gaggini, Melania|Cabiati, Manuela|Del Turco, Serena|Navarra, Teresa|De Simone, Paolo|Filipponi, Franco|Del Ry, Silvia|Gastaldelli, Amalia|Basta, Giuseppina | ||||||||||
| PMID: | 28012856 | ||||||||||
| 5. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2017 Nov 4;493(1):585-591. | ||||||||||
| Title: | Irisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinoma. | ||||||||||
| Author: | Shi, Guangjun|Tang, Nan|Qiu, Jiantao|Zhang, Deguo|Huang, Fei|Cheng, Yayu|Ding, Kun|Li, Weisheng|Zhang, Ping|Tan, Xueying | ||||||||||
| PMID: | 28867187 | ||||||||||